Bellevue Group’s Vaxcyte PCVX Stock Holding History

Bellevue Group’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$426K	Sell
2024 Q4	$985K	Buy
2024 Q3	$1.37M	Sell
2024 Q2	$1.07M	Buy
2024 Q1	$905K	Sell
2023 Q4	$992K	Sell
2023 Q3	$1.55M	Buy
2023 Q2	$1.3M	Buy